Search

everythinglearnresearchcommunity

for

Search:↓

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Compound 7p shows strong potential as an anticancer agent.

AHR ligands could treat inflammatory skin diseases.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Nourkrin effectively promotes hair growth and is well-tolerated without side effects.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Platelet-rich plasma may not be very effective for bone healing and hair growth due to a substance it contains that blocks these processes.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Combination therapy is more effective for prostate volumes over 60 ml.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

2Br-Crebanine and Stephanine reduce inflammation and pain effectively.

JAK inhibitors can enter the skin through hair follicles using a unique pathway.

Adiponectin and bradykinin play important roles in skin health and may help treat skin conditions.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Cannabidivarin (CBDV) may help brain cell growth and survival through the TRPV1 receptor.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Sphingosine 1-phosphate helps control mechanical pain.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

Androgen increases VEGF expression but not VEGFR-2 in rat corpus cavernous.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.